Surgical Treatment of Diabetic Combined Tractional-Rhegmatogenous Retinal Detachment

Abstract

Diabetic macular edema, tractional retinal detachment (TRD) and combined rhegmatogenous retinal detachment (CTRRD) are important causes of vision loss in eyes with proliferative diabetic retinopathy. CTRRD is less common than TRD but has a worse prognosis. Therefore, the treatment of CTRRD is one of the issues that await solutions in current ophthalmology practice. In recent years, it has been shown that the risk of intraocular bleeding during and after the operation is reduced by the use of vascular endothelial growth factor inhibitors before the operation. In addition to bimanual surgery, there are current developments that enable the effective and safe application of segmentation and delamination of proliferative membranes with customized rapid cutters from vitreoretinal small incisions. In addition, the preference for silicone oil as an intraocular tamponade and intraoperative real-time follow-up of vitrectomy with optical coherence tomography has the potential to provide more successful anatomical and functional results.